Literature DB >> 6193066

Natural variation of poliovirus neutralization epitopes.

R Crainic, P Couillin, B Blondel, N Cabau, A Boué, F Horodniceanu.   

Abstract

Poliovirus-neutralizing monoclonal antibodies were prepared against type 1, type 2, and type 3 wild laboratory (Mahoney, MEF1, and Saukett) and Sabin vaccine strains. Fifty-five poliovirus laboratory strains and field isolates were assayed by neutralization index test with a panel of homotypic monoclonal antibodies. A total of 27 monoclonal antibodies were used. Two categories of neutralization epitopes were found, i.e., cross-reacting (K), which is present on almost all strains of the same serotype, and strain-specific (V, variable), either wild (VW) or Sabin (VS). Several distinct neutralization epitopes were defined for each of the three poliovirus serotypes in almost every category. The study of antigenic variation of the Sabin type 1 vaccine virus during replication in human intestine showed that the VS neutralization epitope may be lost and even replaced by the VW epitopes of the parental Mahoney virus. A late isolate from a vaccine-fed infant recovered the complete neutralization epitope pattern of the Mahoney strain. Upon in vivo virus replication, a different kind of antigenic variation was also detected in which an epitope lost its function in virus neutralization but kept its antigenic conformation unaltered. Neutralization epitope analysis demonstrated that the presence of VS epitopes on a field isolate suggests the Sabin origin of the strain when the isolate displays the same epitope pattern as the original Sabin virus, or confirms it when the VS epitope(s) is mutually exclusive of VW epitopes. The lack of VS epitopes on a field isolate does not rule out its being of Sabin origin.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6193066      PMCID: PMC264629          DOI: 10.1128/iai.41.3.1217-1225.1983

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  22 in total

1.  Rapid isolation of antigens from cells with a staphylococcal protein A-antibody adsorbent: parameters of the interaction of antibody-antigen complexes with protein A.

Authors:  S W Kessler
Journal:  J Immunol       Date:  1975-12       Impact factor: 5.422

2.  Antigenic variations among type 1 polioviruses; a study of 16 wild-type strains and 5 variants.

Authors:  H A WENNER; I ARCHETTI; G R DUBES
Journal:  Am J Hyg       Date:  1959-07

3.  THE USE OF A MODIFIED WECKER TECHNIQUE FOR SERODIFFERENTIATION OF TYPE 1 POLIOVIRUSES RELATED AND UNRELATED TO SABIN'S VACCINE STRAIN. II. ANTIGENIC SEGREGATION OF ISOLATES FROM SPECIMENS COLLECTED IN FIELD STUDIES.

Authors:  J H NAKANO; H M GELFAND; J T COLE
Journal:  Am J Hyg       Date:  1963-09

4.  Antigenic analysis of polioviruses by kinetic studies of serum neutralization.

Authors:  W D McBRIDE
Journal:  Virology       Date:  1959-01       Impact factor: 3.616

5.  Intratypic serodifferentiation of poliomyelitis virus strains by strain-specific antisera.

Authors:  A L van Wezel; A G Hazendonk
Journal:  Intervirology       Date:  1979       Impact factor: 1.763

6.  Characterization of type 1 poliovirus by electrophoretic analysis.

Authors:  B Mandel
Journal:  Virology       Date:  1971-06       Impact factor: 3.616

7.  Production of hybrid lines secreting monoclonal anti-idiotypic antibodies by cell fusion on membrane filters.

Authors:  G Buttin; G LeGuern; L Phalente; E C Lin; L Medrano; P A Cazenave
Journal:  Curr Top Microbiol Immunol       Date:  1978       Impact factor: 4.291

8.  Detection by monoclonal antibodies of an antigenic determinant critical for poliovirus neutralization present on VP1 and on heat-inactivated virions.

Authors:  B Blondel; O Akacem; R Crainic; P Couillin; F Horodniceanu
Journal:  Virology       Date:  1983-04-30       Impact factor: 3.616

9.  Functional basis of poliovirus neutralization determined with monospecific neutralizing antibodies.

Authors:  E A Emini; S Y Kao; A J Lewis; R Crainic; E Wimmer
Journal:  J Virol       Date:  1983-05       Impact factor: 5.103

10.  A better cell line for making hybridomas secreting specific antibodies.

Authors:  M Shulman; C D Wilde; G Köhler
Journal:  Nature       Date:  1978-11-16       Impact factor: 49.962

View more
  35 in total

1.  Detection of poliovirus circulation by environmental surveillance in the absence of clinical cases in Israel and the Palestinian authority.

Authors:  Y Manor; R Handsher; T Halmut; M Neuman; A Bobrov; H Rudich; A Vonsover; L Shulman; O Kew; E Mendelson
Journal:  J Clin Microbiol       Date:  1999-06       Impact factor: 5.948

2.  A double-selective tissue culture system for isolation of wild-type poliovirus from sewage applied in a long-term environmental surveillance.

Authors:  Y Manor; R Handsher; T Halmut; M Neuman; B Abramovitz; A Mates; E Mendelson
Journal:  Appl Environ Microbiol       Date:  1999-04       Impact factor: 4.792

3.  Comparative sensitivities of Sabin and Mahoney poliovirus type 1 prototype strains and two recent isolates to low concentrations of glutaraldehyde.

Authors:  M Chambon; C Jallat-Archimbaud; J L Bailly; J M Gourgand; F Charbonne; C Henquell; F Fuchs; H Peigue-Lafeuille
Journal:  Appl Environ Microbiol       Date:  1997-08       Impact factor: 4.792

4.  Use of a multiple restriction fragment length polymorphism method for detecting vaccine-derived polioviruses in clinical samples.

Authors:  Natalia I Romanenkova; Sophie Guillot; Nadejda R Rozaeva; Radu Crainic; Maina A Bichurina; Francis Delpeyroux
Journal:  J Clin Microbiol       Date:  2006-09-06       Impact factor: 5.948

5.  Evolution of the Sabin type 1 poliovirus in humans: characterization of strains isolated from patients with vaccine-associated paralytic poliomyelitis.

Authors:  M M Georgescu; J Balanant; A Macadam; D Otelea; M Combiescu; A A Combiescu; R Crainic; F Delpeyroux
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

6.  Mutations conferring resistance to neutralization with monoclonal antibodies in type 1 poliovirus can be located outside or inside the antibody-binding site.

Authors:  B Blondel; R Crainic; O Fichot; G Dufraisse; A Candrea; D Diamond; M Girard; F Horaud
Journal:  J Virol       Date:  1986-01       Impact factor: 5.103

7.  Persistent poliovirus infection of human neuroblastoma cells.

Authors:  F Colbère-Garapin; C Christodoulou; R Crainic; I Pelletier
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

8.  Molecular pathogenesis of type 2 poliovirus in mice.

Authors:  T Couderc; B Guinguene; F Horaud; A Aubert-Combiescu; R Crainic
Journal:  Eur J Epidemiol       Date:  1989-09       Impact factor: 8.082

9.  High diversity of poliovirus strains isolated from the central nervous system from patients with vaccine-associated paralytic poliomyelitis.

Authors:  M M Georgescu; F Delpeyroux; M Tardy-Panit; J Balanant; M Combiescu; A A Combiescu; S Guillot; R Crainic
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

10.  Identification of vaccine-related polioviruses by hybridization with specific RNA probes.

Authors:  L De; B Nottay; C F Yang; B P Holloway; M Pallansch; O Kew
Journal:  J Clin Microbiol       Date:  1995-03       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.